Acute and subchronic dermal toxicity of nanosilver in guinea pig
Open Access
- 1 April 2011
- journal article
- research article
- Published by Taylor & Francis in International Journal of Nanomedicine
- Vol. 6, 855-862
Abstract
Silver has been used as an antimicrobial agent for a long time in different forms, but silver nanoparticles (nanosilver) have recently been recognized as potent antimicrobial agents. Although nanosilver is finding diverse medical applications such as silver-based dressings and silver-coated medical devices, its dermal and systemic toxicity via dermal use has not yet been identified. In this study, we analyzed the potential toxicity of colloidal nanosilver in acute and subchronic guinea pigs. Before toxicity assessments, the size of colloidal nanosilver was recorded in sizes <100 nm by X-ray diffraction and transmission electron microscopy. For toxicological assessments, male guinea pigs weighing 350 to 400 g were exposed to two different concentrations of nanosilver (1000 and 10,000 µg/mL) in an acute study and three concentrations of nanosilver (100, 1000, and 10,000 µg/mL) in a subchronic study. Toxic responses were assessed by clinical and histopathologic parameters. In all experimental animals the sites of exposure were scored for any type of dermal toxicity and compared with negative control and positive control groups. In autopsy studies during the acute test, no significant changes in organ weight or major macroscopic changes were detected, but dose-dependent histopathologic abnormalities were seen in skin, liver, and spleen of all test groups. In addition, experimental animals subjected to subchronic tests showed greater tissue abnormalities than the subjects of acute tests. It seems that colloidal nanosilver has the potential to provide target organ toxicities in a dose- and time-dependent manner.Keywords
This publication has 18 references indexed in Scilit:
- Assessment of the toxicity of silver nanoparticles in vitro: A mitochondrial perspectiveToxicology in Vitro, 2011
- Nanosilver induces minimal lung toxicity or inflammation in a subacute murine inhalation modelParticle and Fibre Toxicology, 2011
- The growing importance of materials that prevent microbial adhesion: antimicrobial effect of medical devices containing silverInternational Journal of Antimicrobial Agents, 2009
- A case of argyria after colloidal silver ingestionJournal of Cutaneous Pathology, 2006
- In Vitro Cytotoxicity of Nanoparticles in Mammalian Germline Stem CellsToxicological Sciences, 2005
- Silver nanoparticles as antimicrobial agent: a case study on E. coli as a model for Gram-negative bacteriaJournal of Colloid and Interface Science, 2004
- Generalized argyria in two chronic hemodialysis patientsAmerican Journal of Kidney Diseases, 2001
- Longitudinal medical surveillance showing lack of progression of argyrosis in a silver refinerOccupational Medicine, 1999
- Potential nephrotoxic effects of exposure to silver.Occupational and Environmental Medicine, 1987
- ARGYRIA - CLINICAL IMPLICATIONS OF EXPOSURE TO SILVER-NITRATE AND SILVER-OXIDE1979